Haloperidol drug interactions

There are no well controlled studies with HALDOL (haloperidol) in pregnant women. There are reports, however, of cases of limb malformations observed following maternal use of HALDOL along with other drugs which have suspected teratogenic potential during the first trimester of pregnancy. Causal relationships were not established in these cases. Since such experience does not exclude the possibility of fetal damage due to HALDOL, this drug should be used during pregnancy or in women likely to become pregnant only if the benefit clearly justifies a potential risk to the fetus. Infants should not be nursed during drug treatment.

Haloperidol use may lead to the development of symptoms that resemble Parkinson's disease, but that are not caused by Parkinson's. These symptoms may include a taut or mask-like expression on the face, drooling, tremors, pill-rolling motions in the hands, cogwheel rigidity (abnormal rigidity in muscles, characterized by jerky movements when the muscle is passively stretched), and a shuffling gait. Taking the anti-Parkinson drugs benztropine mesylate or trihexyphenidyl hydrochloride along with haloperidol help to control these symptoms. Medication to control Parkinsonian-like symptoms may have to be continued after haloperidol is stopped. This is due to different rates of elimination of these drugs from the body.

Report an adverse event

  • Advertising
  • Privacy
  • Careers at Haymarket
  • Help
  • Terms and Conditions
  • Contact us
  • Editorial Complaint
  • Sign in
  • Register
  • Subscribe
  • About us
  • FAQs
  • MIMS Adviser
  • GPonline
  • MIMS Learning
  • Medeconomics
© Haymarket Media Group Ltd.

Haloperidol drug interactions

haloperidol drug interactions

Media:

haloperidol drug interactionshaloperidol drug interactionshaloperidol drug interactionshaloperidol drug interactionshaloperidol drug interactions